Spinal cord injuries: Scientists probe individual cells to find better treatments

Two top scientists are seeking answers to questions about spinal cord injuries that have long frustrated the development of effective treatments.

Read more

Brain discovery suggests source of lifelong behavioral issues

Improper removal of faulty brain cells during neurodevelopment may cause lifelong behavioral issues, new research from the University of Virginia School of Medicine suggests. The finding also could have important implications for a wide range of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s.

Read more

Study Reveals New Way to Treat Stroke Using an Already FDA-Approved Drug

Granulocyte colony-stimulating factor (GCSF) is currently used to treat neutropenia due to chemotherapy and has been successfully used for patients who require bone marrow transplants. The study is the first to report on the neuroprotective effect of GCSF in vivo and showed that it improved neurological deficits that occur in the first few days following cerebral ischemia. GCSF improved long-term behavioral outcomes while also stimulating a neural progenitor recovery response in a mouse model.

Read more